-
Uncategorized2 months ago
Genome editing of phylogenetically distinct bacteria using cross-species retron-mediated recombineering
Post Content
-
Uncategorized2 months agoSTAT+: Publicly, Kennedy embraces a more moderate MAHA
WASHINGTON — Health secretary Robert F. Kennedy Jr. once said there are no vaccines that are safe and effective. On Wednesday, he seemed to have changed...
-
Uncategorized2 months agoSTAT+: Federal test of AI prior authorization is delaying care for seniors, report says
Washington state hospitals say their Medicare patients are waiting two to four times longer in some cases for procedures that are now subject to prior authorization...
-
Uncategorized2 months ago
OpenAI’s head of health lays out the AI giant’s healthcare ambitions
OpenAI is launching ChatGPT for Clinicians, a free tool for doctors, nurse practitioners, physician assistants and pharmacists. It’s the latest product the AI giant has launched...
-
Uncategorized2 months agoBrain Astrocytes Form Far-Reaching Connections in Mice
A study in mice headed by NYU Langone Health researchers has found that cells long thought to play a secondary role in brain function build their...
-
Uncategorized2 months ago
AbbVie’s North Carolina $1.4B manufacturing site to finish during Trump’s term
AbbVie has provided new details about its $100 billion pledge to the US, budgeting $1.4 billion for its first manufacturing campus in North Carolina. Construction of...
-
Uncategorized2 months agoSTAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
You’re reading the web version of STAT’s popup newsletter, AACR in 30 seconds, your guide to what’s happening at the American Association of Cancer Researchers’ annual...
-
Uncategorized2 months ago
FDA issues warning letter after GLP-1 manufacturer refuses inspectors access
New Life told FDA inspectors that they lacked the authority to enter parts of a facility where it made the GLP-1 receptor agonists semaglutide and tirzepatide.
-
Uncategorized2 months ago
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies
Andelyn Biosciences and ENCell, both CDMOs, signed a collaboration agreement to create a strategic manufacturing bridge between the United States and Asia-Pacific (APAC) regions to accelerate...
-
Uncategorized2 months ago
BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work
BridgeBio Oncology Therapeutics is replacing CEO Eli Wallace, putting its CSO Pedro Beltran in the role, and making board member Neil Kumar executive chairman. The changes...
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
